Autres langues Catalent, Inc.

Actions

Marché Fermé - Nyse Autres places de cotation 22:00:01 15/07/2024			Varia. 5j.	Varia. 1 janv.
57,84 ^USD	+0,45 %		+1,28 %	+28,73 %

24/06	Le fabricant de Wegovy, Novo Nordisk, va dépenser 4,1 milliards de dollars pour stimuler la production aux États-Unis	RE
29/05	Les actionnaires de Catalent approuvent l'accord avec Novo Holdings	MT

RECOMENDACIONES DE LOS ANALISTAS UK/EE.UU: Albemarle, Snowflake, Tesla, Diageo, Johnson Matthey...	12/07
Analyst recommendations: Albemarle, Snowflake, Tesla, Diageo, Johnson Matthey...	12/07
Novo Nordisk, fabricante de Wegovy, invertirá 4.100 millones de dólares en impulsar fabricación en EEUU	24/06
Wegovy-maker Novo Nordisk to spend $4.1 bln to boost US manufacturing	24/06
Ardena appoints Jeremie Trochu as Chief Executive Officer	07/06
Catalent Shareholders Approve Deal With Novo Holdings	29/05
Catalent stockholders approve deal with Novo Holdings	29/05
Catalent Stockholders Approve Transaction with Novo Holdings	29/05
Novo Nordisk Selling $5 Billion in Bonds to Back Catalent Deal	14/05
Novo Nordisk Plans First Bond Sale in Two Years	14/05
Novo Nordisk Plans First Bond Sale in 2 Years	13/05
MOVES -Lazard hires veteran healthcare dealmaker Colocci as vice chairman	09/05
Catalent: Fiscal Q3 Earnings Snapshot	09/05
Earnings Flash (CTLT) CATALENT Posts Q3 Revenue $1.07B	08/05
Catalent, Inc. Reports Third Quarter Fiscal 2024 Results	08/05
Catalent, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	08/05
Siren Biotechnology and Catalent Enter Partnership for Manufacturing of AAV Gene Therapies for Cancer	08/05
Top Midday Stories: Apple's Dividend, Buybacks Announcements; Amgen Obesity Drug Trial Results; Exxon Completes Pioneer Acquisition	03/05
Catalent, Novo Nordisk Antitrust Review Extended by FTC	03/05
FTC Seeks More Info On $16.5 Billion Novo/Catalent Deal	03/05

Aucun résultat pour cette recherche